The Hartford Healthcare Fund Class R5 (HGHTX)
| Fund Assets | 788.79M |
| Expense Ratio | 1.04% |
| Min. Investment | $2,000 |
| Turnover | 40.00% |
| Dividend (ttm) | 1.97 |
| Dividend Yield | 4.93% |
| Dividend Growth | n/a |
| Payout Frequency | Annual |
| Ex-Dividend Date | n/a |
| Previous Close | 40.40 |
| YTD Return | -4.36% |
| 1-Year Return | -16.49% |
| 5-Year Return | 5.54% |
| 52-Week Low | 38.55 |
| 52-Week High | 51.58 |
| Beta (5Y) | n/a |
| Holdings | 91 |
| Inception Date | Dec 22, 2006 |
About HGHTX
The Hartford Mutual Funds, Inc. Hartford Healthcare Fund Class R5 is an open-end mutual fund specializing in the global healthcare sector. Its primary objective is to achieve long-term capital appreciation by investing at least 80% of its assets in equity securities of healthcare-related companies worldwide. Managed jointly by Hartford Funds Management Company, LLC and Wellington Management Company LLP, the fund takes a diversified approach, targeting industries such as pharmaceuticals, biotechnology, medical devices, health information services, and emerging healthcare subsectors. This fund employs fundamental analysis to select both growth and value stocks across large, mid, and small capitalizations. With over 100 holdings and a significant portion of assets allocated to its top holdings, it aims to capture opportunities across the rapidly evolving healthcare landscape. The fund serves investors seeking exposure to the innovations and defensive qualities characteristic of the healthcare industry, benchmarking its performance against indices like the S&P Composite 1500 Health Care Index and the S&P 500 Index. It is notable for its broad sector coverage and global investment mandate.
Performance
HGHTX had a total return of -16.49% in the past year, including dividends. Since the fund's inception, the average annual return has been 8.81%.
Top 10 Holdings
46.52% of assets| Name | Symbol | Weight |
|---|---|---|
| Eli Lilly and Company | LLY | 12.89% |
| UnitedHealth Group Incorporated | UNH | 6.80% |
| Boston Scientific Corporation | BSX | 4.90% |
| Intuitive Surgical, Inc. | ISRG | 4.17% |
| Merck & Co., Inc. | MRK | 3.69% |
| Vertex Pharmaceuticals Incorporated | VRTX | 3.34% |
| Johnson & Johnson | JNJ | 2.91% |
| Cencora, Inc. | COR | 2.89% |
| Gilead Sciences, Inc. | GILD | 2.47% |
| Thermo Fisher Scientific Inc. | TMO | 2.46% |
Dividend History
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Dec 27, 2024 | $0.07368 | Dec 30, 2024 |
| Dec 11, 2024 | $1.89862 | Dec 12, 2024 |
| Dec 12, 2022 | $0.36137 | Dec 13, 2022 |
| Dec 10, 2021 | $4.37361 | Dec 13, 2021 |
| Dec 10, 2020 | $5.16605 | Dec 11, 2020 |
| Dec 10, 2019 | $2.36232 | Dec 11, 2019 |